BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -87.35% | 55.67% | -226.67% | 78.49% | -29.11% |
| Total Depreciation and Amortization | 74.40% | 0.20% | -1.57% | -41.33% | 157.42% |
| Total Amortization of Deferred Charges | 249.49% | 18.12% | 6.98% | -14.38% | -0.22% |
| Total Other Non-Cash Items | -199.28% | -47.86% | -121.94% | -84.45% | -9.68% |
| Change in Net Operating Assets | 209.24% | -544.05% | -71.37% | 204.79% | -237.42% |
| Cash from Operations | 59.67% | 10.18% | -578.16% | 119.40% | -818.72% |
| Capital Expenditure | 147.17% | -- | 100.00% | -90.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 147.17% | -- | 100.00% | -90.00% | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -3,237.04% | 31.74% | 14.83% | 98.10% | -3,728.82% |
| Issuance of Common Stock | -- | 100,252.63% | 35.71% | -99.97% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.60% | -- | 100.00% | 97.40% | -1,941.34% |
| Cash from Financing | -147.69% | -11.10% | 3,748.05% | -103.46% | 1,975.81% |
| Foreign Exchange rate Adjustments | -128.25% | 271.49% | 138.84% | -135.00% | 2,169.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -352.13% | -5.11% | 218.38% | -12.38% | 179.06% |